Literature DB >> 10395267

Arresting donor hearts with extracellular-type cardioplegia prevents vasoconstriction induced by UW solution.

Y Tanoue1, S Morita, M Hisahara, R Tominaga, Y Kawachi, H Yasui.   

Abstract

The effects of arresting donor hearts with University of Wisconsin solution was investigated. Donor dogs were divided into two groups according to the technique used for arresting the heart. In group I (n = 6) the heart was arrested with University of Wisconsin solution, whereas in group II (n = 6) extracellular-type cardioplegia (K+ = 20 mmol/liter) was used to induce cardioplegic arrest. Aortic root pressure was measured during the infusion of solution at constant flow. In both groups, the hearts were then flushed and stored in cold University of Wisconsin solution for 6 h. The hearts were transplanted orthotopically and disconnected from cardiopulmonary bypass. Left ventricular function was evaluated by pressure-volume relations using a conductance catheter. Peak aortic root pressure during the infusion was significantly higher in group I than in group II, although post-transplant left ventricular function was similar in both groups. Although there was no difference in cardiac function after implantation, donor hearts should be arrested by extracellular-type cardioplegia to prevent coronary vasoconstriction associated with preservation in University of Wisconsin solution.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10395267     DOI: 10.1016/s0967-2109(98)00064-7

Source DB:  PubMed          Journal:  Cardiovasc Surg        ISSN: 0967-2109


  2 in total

1.  Effect of phosphodiesterase III inhibitor on contractility, afterload, and vascular capacitance during right heart bypass preparation.

Authors:  Y Tanoue; S Morita; I Nagano; Y Ochiai; R Tominaga; Y Kawachi; H Yasui
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-10

2.  Ventricular energetics in aortic root replacement for annuloaortic ectasia with aortic regurgitation.

Authors:  Yoshihisa Tanoue; Yukihiro Tomita; Shigeki Morita; Ryuji Tominaga
Journal:  Heart Vessels       Date:  2009-01-23       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.